This Article explains the dichotomy of thought in the medical field over the classification of Alzheimer patients. New studies and medical studies have tried to change the majority of Alzheimer’s patients to be labeled as Mild Cognitive Impairment patients (MCI). While this seems to be a medical breakthrough, it really is just confusing the industry. The medical professionals behind this study are trying to further separate two diseases that are almost exactly alike. In my opinion, there really is no difference between mild Alzheimer’s and MCI, but some professionals say otherwise. "We are really now working on trying to identify exactly where people will fit in the continuum of Alzheimer's disease," Thies said. Thies is a medical professional advocating the split of disease between the two entities. He says that many patients diagnosed with Alzheimer's disease are misdiagnosed. However, a study shows that 99.8 percent of Alzheimer's patients that were labeled as mild carriers of this disease would be changed to MCI patients. They would no longer be classified as Alzheimer's patients. While this seems to be very easily changed, it isn't.
If this classification process was instituted, the cost in millions of jobs, millions of donation dollars, and medical dichotomy would fully change the economy. Alzheimer's currently affects almost 3 million people in the United States. A significant change in insurance policies and medical care for that many people would have drastic effects on the economy. People would buy into the fallacy that MCI and Alzheimer's are actually two separate diseases, whereas in reality, they are actually just different stages of memory loss. In my opinion, until more research is done, no change to Alzheimer's patients should be publicized because the American public is known for buying into lies and without realizing it, changing the way they live to substantiate these lies.